Flow Cytometry Core

流式细胞仪核心 摘要 最初成立流式细胞仪核心是为了满足项目和试点项目的流式细胞仪需求 最初的Cobre第一阶段应用程序的。该中心提供干细胞和稀有细胞分离方面的专业知识， 细胞分选和细胞表型分析，通过为流动提供最先进的仪器 Cobre研究人员以及罗德的临床和基础研究社区对细胞学的需求 小岛。今天，流式细胞术核心继续发挥这一关键作用，并支持大量研究 罗德岛医院和该州不同机构的方案、项目和不同的研究领域 罗德岛。它仍然被大量使用，部分原因是科布雷的Here的大力支持和成功 在罗德岛，也是流式细胞术给研究带来的战略重要性和基础相关性 整个社区。这是罗德岛医院唯一的研究流式细胞仪核心设施，也是唯一的 研究流式细胞仪核心设施，提供5激光分选仪、4激光分析仪和质量细胞仪 在这个州。在许多不同的研究中，流式细胞术仍然是研究人员非常有用的工具 纪律。该机构一直慷慨地为流式细胞术提供行政和财政支持 核心。值得注意的是，今年罗德岛医院购买并安装了Fluidigm Helios CyTOF系统， 现在可以通过Cobre Flow细胞术核心获得这一结果。该CyTOF平台将用于临床 和罗德岛州的基础研究人员，并表现出对 建议的Cobre Flow细胞计数核心获得成功。采用最先进的新仪器和核心 旨在扩大临床研究项目的扩展计划，我们的核心处于有利地位 继续增长，实现长期的财务可持续性。

Flow Cytometry Core Abstract The Flow Cytometry Core was initially formed to fulfill the flow cytometry needs of the projects and pilot projects of the original COBRE Phase I application. The Core provided expertise in stem cell and rare cell separations, cell sorting and cell phenotyping analysis, by making available, state-of-the-art instrumentation for the flow cytometry needs of the COBRE investigators as well as the clinical and basic research community in Rhode Island. Today, the Flow Cytometry Core continues to fulfill this critical role and supports a multitude of research programs, projects and diverse research areas at Rhode Island Hospital and different institutions in the state of Rhode Island. It remains heavily utilized, partially due to the strong support and success of the COBRE’s here in Rhode Island but also the strategic importance and basic relevance that flow cytometry brings to the research community at large. This is the only research flow cytometry core facility at Rhode Island Hospital and the only research flow cytometry core facility that offers access to a 5-laser sorter, 4-laser analyzer and a mass cytometer in the state. Flow cytometry remains an extremely useful tool for researchers over many different research disciplines. The institution has been generous with its administrative and fiscal support of the Flow Cytometry Core. Notably, this year Rhode Island Hospital has purchased and installed, a Fluidigm Helios CyTOF system, that is now available through the COBRE Flow Cytometry Core. This CyTOF platform will be utilized by clinical and basic researchers in the State of Rhode Island and shows a high level of support and dedication to the success of the proposed COBRE Flow Cytometry Core. With the new state-of-the-art instrumentation and Core expansion plan directed towards expanding inclusion of clinical research projects, our Core is well positioned to continue its growth and achieve long-term financial sustainability.